The Week Ahead: COS...
Health Care: Drugs
Talon Therapeutics Inc. (TLON: OTC)
$0.41 -0.01 | -2.38%
05/24/13 - 03:45 PM ET
32.84K / 37.90K
Vol / Avg. Vol:0.42 / 0.42
Open / Prev. Close:0.41 - 0.43
Today's Range:0.40 - 1.83
52 Wk Range:-12.50%
Performance YTD:TheStreet Rating:
Portfolios with TLON
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
Latest TLON Headlines from TheStreet
- Talon Therapeutics, Inc. Reports Fourth Quarter And Year End 2012 Financial Results 04.01.13 | 09:04 am
- Talon Therapeutics To Host A Conference Call To Report 2012 Financial Results And Business Update On April 1, 2013 03.19.13 | 09:03 am
- Talon Therapeutics Announces Review Of Strategic Alternatives 01.07.13 | 09:01 am
- Talon Therapeutics Appoints Elizabeth Weatherman To Board Of Directors 01.04.13 | 09:01 am
- Talon Therapeutics, Inc. Reports Second Quarter 2012 Financial Results 08.13.12 | 09:08 am
- Talon Therapeutics' Marqibo(R) (vinCRIStine Sulfate LIPOSOME Injection) Granted Accelerated Approval By FDA 08.09.12 | 12:08 pm
- Biotech Stock Mailbag: Mela, Osiris, Talon 08.03.12 | 06:08 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- Talon Therapeutics: FDA Panel Live Blog 03.21.12 | 07:03 am
Press Releases for TLON
Partner Headlines for TLON
